ArticleTechnology in cancer research & treatment

A Prognostic Risk Signature Based on Myeloid-Derived Suppressor Cells and Regulatory T Cells in Clear Cell Renal Cell Carcinoma.

Zhaoyu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.